Populära just nu
Redeye updates its view on Flexion Mobile following its strong Q4 2022 report released on March 22.
Administer reports its H2/2022 results on March 30th.
Q-linea is in the early stage of its targeted European launch strategy...
Redeye thinks the presented study of global and European DMS adoption supports Smart Eye becoming ca...
För Alzinova stundar en spännande period då ny interimdata från Alzheimer-projektet ALZ-101 ska läsa...
Redeye is encouraged to learn that Faron has received positive FDA feedback and recommendations for ...
Ökat fokus på affärsutveckling under 2022 och flera pågående diskussio...
CoinShares International (CS) rapporterade en måttlig EBITDA-förlust p...
Eevia Health Plc (publ) (”Eevia Health”, “Eevia” or “the Company”) is at a stage where the Company i...
Redeye gives a short comment on the announced rights issue and pauses its coverage.
Redeye comments on Flexion Mobiles Q4 2022 report. Strong revenue growth of 108% y/y, despite a chal...
Redeye comments on the outcome of Zwipe’s rights issue, which was subs...
Completes a SEK 52.6m directed share issue 4.5% EPS dilution, 4.
AcuCort AB (”AcuCort” eller ”Bolaget”) har erhållit godkännande inom samtliga nordiska länder för Bo...
OrderYOYO published, March 20, the company’s annual report of 2022, and are showing progress.
Redeye responds to Wyld’s press release from today, revealing the company’s intention to upgrade its...
5% Q1e adj. EBITA margin and 7% org. growth Limited adj.
AlzeCure möts av ett ökat intresse från större läkemedelsbolag och mål...
Investors House hosted a webcast CMD on 20 March. The company gave an update on current operations o...
Redeye states that Q4 came in on the weak side and that the outlook for Q1 was weak, but far from ca...
On March 20, 2023, Brain+ A/S (“Brain+” or “the Company”) announced that the Danish municipality Her...
EcoRub tillkännagav den 2 mars att bolaget lanserar en ny produktserie...
Raising SEK 122m at a SEK 1.3 subscription price The board of director...
Redeye updates its view on Energy Save after the Q3 2022/2023 report.
Redeye comments on Aritificial Solutions Q4’22 report.